News

Siemens Healthineers Biograph Vision Quadra Total-Body PET Scanner. Credit: Siemens Healthineers

Cambridge to host cutting-edge total-body PET scanner as part of nationwide imaging platform

2 September 2025

A new total-body PET scanner to be hosted in Cambridge – one of only a handful in the country – will transform our ability to diagnose and treat a range of conditions in patients and to carry out cutting-edge research and drug development. The scanner, funded through a £5.5m investment from the UKRI Medical Research...

Professor Ganiyat Oloyede visiting the Yusuf Hamied Department of Chemistry

Cambridge-Nigeria research collaboration to advance hypertension imaging

13 August 2025

Professor Ganiyat Oloyede, a leading expert in Medicinal Chemistry from the University of Ibadan, Nigeria, recently completed a research visit to the Molecular Imaging Chemistry Laboratory (MICL) in Cambridge. Her stay, from June 5th to 22nd, marks a significant step in a collaborative project with MICL Director, Professor...

First ever mitochondrial disease treatment approved by NHS England

7 August 2025

The first ever treatment for a mitochondrial condition has been approved for use on the NHS in England in a major breakthrough in the fight against the disease. The National Institute for Health and Care Excellence (NICE) has announced the approval of Idebenone (Raxone) for the treatment of Leber’s Hereditary Optic...

News - The Times: Tim Rittman features in UK Biobank project

16 July 2025

Dr Timothy Rittman was featured in the Times on the coverage of the 100,000th person scanned for the whole body scanning project by UK Biobank. His lab have been using some of the first tranches of scanning data for research on Alzheimer's disease and rarer neurodegenerative disorders. Read the article mentioning Dr...

The CADASIL clinic team (left to right) Amy Jolly, postdoctoral research associate, Natalia Owen, PhD student, Kate Rose, medical secretary and Professor Hugh Markus.

Outlook for people with rare stroke condition has improved with the help of specialist care in Cambridge

15 July 2025

Greater awareness and the availability of specialist care has helped to delay the average onset of symptoms caused by a rare genetic condition by around five years, according to a recent study. The condition causes early-onset strokes and increases risk of dementia, often affecting multiple members of the same family...

Close-up views of nerve fibres in mice with damaged spinal cords that received stem cell treatment, where nerve fibres appear covered and healthy, indicating repair.

Cambridge study shows stem cell grafts can restore myelin in MS lesions in mice

7 July 2025

A study led by Cambridge researchers has shed light on how neural stem cell grafts could help restore myelin in the central nervous system. The findings suggest that neural stem cell-based therapies hold promise as a potential treatment for chronic demyelinating disorders, particularly progressive multiple sclerosis...

PhD student Pranathi Prasad wins CSAR Student Award

1 July 2025

Clinical Neurosciences PhD student Pranathi Prasad has won a CSAR student award for applied research. The the Cambridge Society for the Application of Research (CSAR) PhD Student Awards of £1,000 each, are intended to recognise outstanding research with real world application and to assist students to pursue their research...

Illustrative brain image for funding win for technology to tackle brain injury

Double funding win for technology to tackle brain injury

26 June 2025

Two cutting-edge medical technologies from Addenbrooke's to tackle brain injury are among 35 awarded a share of £3m from the National Institute for Health and Care Research (NIHR). The projects are funded through the Invention for Innovation (i4i) Funding At the Speed of Translation (FAST) 4 Awards supporting healthcare...

Innovative FTD gene therapy trial recruiting in Cambridge

18 June 2025

Addenbrooke’s Hospital is one of the sites participating in an innovative, international trial of a novel gene therapy that offers the potential of a cure for patients with a particular inherited form of frontotemporal dementia (FTD). FTD is the leading cause of dementia in those under the age of 65 years. It is a...

Gita Khalili Moghaddam copyright University of Cambridge

Gita Khalili Moghaddam named one of top 13 women changemakers in the UK

17 June 2025

Gita Khalili Moghaddam has been named one of the top 13 women changemakers in the UK by the Royal Society. The award was given for the translational impact of her research and entrepreneurial activities. This work originated during her PhD at Cambridge under the supervision of Prof Chris Lowe and was been supported by...

Cambridge to host cutting-edge total-body PET scanner as part of nationwide imaging platform

Cambridge-Nigeria research collaboration to advance hypertension imaging

First ever mitochondrial disease treatment approved by NHS England

News - The Times: Tim Rittman features in UK Biobank project

Outlook for people with rare stroke condition has improved with the help of specialist care in Cambridge

Cambridge study shows stem cell grafts can restore myelin in MS lesions in mice

PhD student Pranathi Prasad wins CSAR Student Award

Double funding win for technology to tackle brain injury

Innovative FTD gene therapy trial recruiting in Cambridge

Gita Khalili Moghaddam named one of top 13 women changemakers in the UK

Join us online

li_blue.png

bsky_blue.png

Study at Cambridge

About the University

Research at Cambridge